The device was not returned for evaluation.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other incidents.It was reported that the 5.0x12mm herculink stent delivery system (sds) had resistance during advancement due to the anatomy and force was applied.It should be noted that the rx herculink elite peripheral stent system instructions for use (ifu) states: should unusual resistance be felt at any time during stent advancement, deployment, or retraction of the stent, the entire system should be removed together with the introducer sheath or guiding catheter as a single unit.If possible, retain the guide wire position for subsequent vessel access.Applying excessive force to the stent delivery system can potentially result in loss or damage to the stent and stent delivery system components, or damage to the vessel.It is unknown if the ifu deviation contributed to the reported event.The investigation determined the reported difficulties and subsequent treatment, including device embedded in tissue or plaque and delay to treatment/therapy, appears to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|